Dr. Nicholas Ray Rowan

MBBS

ENT/ Otorhinolaryngologist

8 years experience overall

Al Jaddaf Clemenceau Medical Center Fz-Llc
Prime 
Verified details

About Dr. Nicholas Ray Rowan

Nicholas Rowan is an endoscopic sinus and skull base surgeon who is coread more

Practices at

Address
Dubai Healthcare City Phase 2 - Al Jaddaf, Landmark : Fm Supermarket Trouvaille Restaurant
Timings
MON 12:00 PM
06:00 PM
TUE 12:00 PM
06:00 PM
View all timings
Photos

services

Rhinoplasty
Reconstructive Middle Ear Surgery
Surgery Of The Facial Nerve
Surgery for Snoring
Thyroplasty
Head and Neck Tumor / Cancer Surgery
Laser Surgeries for Head and Neck Lesions
Phonosurgery
Orbital & Optic Nerve Decompression
Canalith Repositioning (CR)
Show More services (84)
Common Questions
Q :
Where does Dr. Nicholas Ray Rowan practice?
A :
Dr. Nicholas Ray Rowan practices at Clemenceau Medical Center Fz-Llc - Al Jaddaf.
Q :
How can I take Dr. Nicholas Ray Rowan's appointment ?
A :
You can take Dr. Nicholas Ray Rowan's appointment online through Practo for in-clinic visit with the doctor.
Q :
Why do patients visit Dr. Nicholas Ray Rowan?
A :
Patients frequently visit Dr. Nicholas Ray Rowan for Rhinoplasty, Reconstructive Middle Ear Surgery, Surgery Of The Facial Nerve. To see more reasons visit the doctor's profile on Practo.
Q :
What is Dr. Nicholas Ray Rowan's education qualification?
A :
Dr. Nicholas Ray Rowan has the following qualifications - MBBS. You can book the doctor through the doctor's profile on Practo.
Q :
What does Dr. Nicholas Ray Rowan specialises in ?
A :
Dr. Nicholas Ray Rowan specialises as ENT/ Otorhinolaryngologist.

Other Information

Specializations

ENT/ Otorhinolaryngologist

Education

MBBS - Houston University, 2018

Experience

2018 - 2022 Specialist in otolaryngology Head Neck surgery (P) at Johns Hopkins Medicine
Consultant Otolaryngology at Clemenceau Medical Center FZ-LLC

Memberships

Alpha Omega Alpha Honor Medical Society (AOA)
American Academy of Otolaryngology

Registrations

06532118-001 Dubai Health Authority (DHA), 2024